Implants with absorbable and non-absorbable features for the treatment of female pelvic conditions
First Claim
Patent Images
1. An implant configured for transvaginal insertion into a female patient to treat a pelvic disorder or disease, the implant comprising:
- a non-absorbable mesh layer, the non-absorbable mesh layer including an absorbable material, the absorbable material being a bioactive agent that is selected from at least one of an antibiotic, an antimicrobial, an inhibitor of epithelial cell activation, a migration, or a compound that enhances wound regeneration, the absorbable material being in a form of at least one of a coating on the non-absorbable mesh layer, an absorbable filament associated with the non-absorbable mesh layer, or a second layer associated with the non-absorbable mesh layer;
an absorbable layer, the absorbable layer being formed from a bioabsorbable polymer,the absorbable layer has a rate of degradation that is faster than a rate of degradation of the absorbable material in the non-absorbable mesh layer; and
an attachment member disposed on the absorbable layer, the attachment member being configured to absorb more rapidly in vivo than the absorbable layer.
6 Assignments
0 Petitions
Accused Products
Abstract
Described are methods, devices, and systems related to implants for the treatment of a female pelvic condition. The implants include absorbable and non-absorbable materials and can be introduced into the pelvic area transvaginally. Meshes of the invention provide benefits relating to improved tissue integration into the mesh, reduced infection likelihood, improved patient comfort following implantation, or combinations of thereof.
-
Citations
19 Claims
-
1. An implant configured for transvaginal insertion into a female patient to treat a pelvic disorder or disease, the implant comprising:
-
a non-absorbable mesh layer, the non-absorbable mesh layer including an absorbable material, the absorbable material being a bioactive agent that is selected from at least one of an antibiotic, an antimicrobial, an inhibitor of epithelial cell activation, a migration, or a compound that enhances wound regeneration, the absorbable material being in a form of at least one of a coating on the non-absorbable mesh layer, an absorbable filament associated with the non-absorbable mesh layer, or a second layer associated with the non-absorbable mesh layer; an absorbable layer, the absorbable layer being formed from a bioabsorbable polymer, the absorbable layer has a rate of degradation that is faster than a rate of degradation of the absorbable material in the non-absorbable mesh layer; and an attachment member disposed on the absorbable layer, the attachment member being configured to absorb more rapidly in vivo than the absorbable layer. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. A method for surgically implanting a mesh in a female patient to treat a pelvic disorder or disease, the method comprising:
-
(a) providing an implant, the implant including; a non-absorbable mesh layer, the non-absorbable mesh layer including an absorbable material, the absorbable material being a bioactive agent that is least one of an antibiotic, an antimicrobial, an inhibitor of epithelial cell activation, a migration, or a compound that enhances wound regeneration, the absorbable material being in a form of at least one of a coating on the non-absorbable mesh layer, an absorbable filament associated with the non-absorbable mesh layer, or a second layer associated with the non-absorbable mesh layer; an absorbable layer, the absorbable layer being formed from a bioabsorbable polymer, the absorbable layer has a rate of degradation that is faster than a rate of degradation of the absorbable material in the non-absorbable mesh layer; and an attachment member disposed on the absorbable layer, the attachment member being configured to absorb more rapidly in vivo than the absorbable layer; (b) creating an incision in vaginal tissue of the female patient; and (c) transvaginally inserting the implant into the female patient so the absorbable layer faces the incision site, wherein the implant treats the pelvic disorder or disease. - View Dependent Claims (19)
-
Specification